AGP Picks
View all

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 23, 2026

Fortrea dan Omico Bekerjasama Memajukan Pembangunan Ubat Onkologi Dipacu Biomarker
Colaboração Entre Fortrea e Omico Impulsiona Desenvolvimento de Medicamentos Oncológicos Guiados por Biomarcadores
ความร่วมมือระหว่าง Fortrea และ Omico…
Fortrea 与 Omico 携手,推进生物标志物导向的肿瘤药物开发
Fortrea 與 Omico 攜手合作,推動生物標記主導的腫瘤藥物開發
G6 Hospitality Signs Development Agreement for New Studio 6 Plus in Marshall, Illinois
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
钛动科技发布行业首个Pro-Agent, Navos Pro定义结果导向的AI for Work | TGC 2026科技增长大会
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
Top ALK PPS Diaphragm Manufacturer Jiangsu Jushuo Advances Material Solutions
Muck Rack Named as a Leader in the 2026 First-Ever Gartner® Magic Quadrant™ for PR and Media Monitoring Tools
Houston Empire Gold Buyers Passes 700 Google Reviews, Cementing Its Reputation as the Most Trusted Place to Get Cash for Gold in Houston, TX
Das KFSH verkürzt die Wartezeit auf einen Termin für eine Echokardiographie von 126 Tagen auf einen Tag
Le KFSH réduit le délai d’attente pour un rendez-vous d’échocardiographie de 126 jours à un seul
KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells
eClinical Solutions Market to Reach USD 25.22 Billion by 2030, Growing at a CAGR of 13.9% – MarketsandMarkets™
GOA Therapeutics Presents New Data at ANESTHESIOLOGY® 2026 for GOA26, a First-in-Class Candidate for Acute Alcohol Intoxication and Poisoning
Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026
How Peptide Conjugate Developability Is Shaped Before a Candidate Is Nominated
Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.